摘要
组织缺氧可能发生在许多疾病特别是在恶性实体瘤的发生和发展过程中。靶向缺氧是诊断、监测和治疗肿瘤最重要的特征之一。本文综述了目前氧敏感的成像剂用于靶向肿瘤缺氧,如正电子发射计算机断层扫描/单光子发射计算机断层扫描放射性核素标记的示踪剂,磁共振成像造影剂的缺氧检测,以及缺氧敏感的光学成像探头。研究人员利用纳米技术作为一个有用的工具包以提高氧敏感成像剂的作用。我们强调纳米技术在这些材料和技术中的进步和影响。这篇评论表明,缺氧显像剂具有广阔的前景,并可能提供有用的肿瘤诊断和预后信息。
关键词: 成像剂;磁共振成像;光学成像;氧传感;放射;肿瘤缺氧。
Current Medicinal Chemistry
Title:Imaging Agents in Targeting Tumor Hypoxia
Volume: 23 Issue: 17
Author(s): Yun Zeng, Jingwen Ma, Shaojuan Zhang, Daocheng Wu
Affiliation:
关键词: 成像剂;磁共振成像;光学成像;氧传感;放射;肿瘤缺氧。
摘要: Tissue hypoxia may occur in many diseases, specifically during the occurrence and growth of malignant solid-tumors. Targeting hypoxia is one of the most significant characteristics of tumors in diagnosis, monitoring, and treatment. This review summarizes the current oxygen-sensitive imaging agents used to target tumor hypoxia, including positron-emission computed tomography/single photon-emission computed tomography radionuclide labeled tracers, magnetic resonance imaging contrast agents for hypoxia detection, and hypoxia-sensitive optical imaging probes. Researchers have utilized nanotechnology as a useful toolkit to improve the effects of oxygen-sensitive imaging agents. We emphasize the progress and influence of nanotechnology in these materials and technologies. This review demonstrates that hypoxia imaging agents have promising prospects, and may provide helpful information for tumor diagnosis and prognosis.
Export Options
About this article
Cite this article as:
Yun Zeng, Jingwen Ma, Shaojuan Zhang, Daocheng Wu , Imaging Agents in Targeting Tumor Hypoxia, Current Medicinal Chemistry 2016; 23 (17) . https://dx.doi.org/10.2174/0929867323666160321122023
DOI https://dx.doi.org/10.2174/0929867323666160321122023 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting RANK/RANKL in the Treatment of Solid Tumours and Myeloma
Current Pharmaceutical Design Carbonic Anhydrase Inhibitors and the Management of Cancer
Current Topics in Medicinal Chemistry Current Advances in Retroviral Gene Therapy
Current Gene Therapy Oncogenic Properties of HIV-Tat in Colorectal Cancer Cells
Current HIV Research Innovative Cancer Treatments that Augment Radiotherapy or Chemotherapy by the Use of Immunotherapy or Gene Therapy
Recent Patents on Anti-Cancer Drug Discovery Prolyl-Specific Peptidases and Their Inhibitors in Biological Processes
Current Chemical Biology Curcumin in Combined Cancer Therapy
Current Pharmaceutical Design Clinical Development of mTOR Inhibitors: A Focus on Lymphoma
Reviews on Recent Clinical Trials Targeting Tumors Using Estrogen Receptor Ligand Conjugates
Current Cancer Drug Targets A Comparison of the Inhibitory Effects of Anti-Cancer Drugs on Thioredoxin Reductase and Glutathione S-Transferase in Rat Liver
Anti-Cancer Agents in Medicinal Chemistry The Long-Term Impact of Early Adversities on Psychiatric Disorders: Focus on Neuronal Plasticity
Current Pharmaceutical Design When Neighbors Talk: Colon Cancer Cell Invasion and Tumor Microenvironment Myofibroblasts
Current Drug Targets Nanoparticle-Delivered Quercetin for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Anaplastic Lymphoma Kinase Inhibitors in Non-Small Cell Lung Cancer
Current Drug Targets Cytotoxic and Antitumor Potentialities of Aporphinoid Alkaloids
Current Medicinal Chemistry - Anti-Cancer Agents Cancer Proteomics: New Horizons and Insights into Therapeutic Applications
Current Proteomics Ocular Toxicities in Cancer Therapy: Still Overlooked
Current Cancer Therapy Reviews Immunotherapy in Breast Cancer- Paving New Roads?
Current Molecular Pharmacology Recurrent Left Atrial Low-grade Malignant Inflammatory Myofibroblastic Tumor Characterized by Cardiovascular Magnetic Resonance
Current Medical Imaging Heterocyclic Chalcone Analogues as Potential Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry